Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Honokiol and Its Emerging Role in Breast Cancer Therapy.

Cancers·2026
Same author

Comment on "Assessing the environmental, financial, and social impact of immediate-release morphine tablets compared to oral morphine solution" by Tahir et al.

The International journal of pharmacy practice·2026
Same author

Differential Expression of hsa-miR-34c-5p, hsa-miR-200b-3p, hsa-miR-320a-3p and Their Target Genes Determine Survival in Clear-Cell Renal Cell Carcinoma.

Annals of surgical oncology·2026
Same author

Comment on "Use of bundle for prevention of infiltration in peripheral intravenous catheters in hospitalized children: A scoping review".

Journal of infection prevention·2026
Same author

ASO Author Reflections: MicroRNAs and Their Target Genes as a Potential Biomarker and Determine Survival in Clear Cell Renal Cell Carcinoma.

Annals of surgical oncology·2026
Same author

Comment from Ailani et al on "Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques".

Journal of pharmaceutical sciences·2026
Same journal

Bacteriological profile of secondary infections following snakebite envenomation's: A systematic literature review.

Experimental and molecular pathology·2026
Same journal

3D virtual histopathology of human breast tissues using an X-ray grating interferometry micro CT system.

Experimental and molecular pathology·2026
Same journal

Pan-cancer analysis identifies GPRIN1 as a prognostic biomarker and promoter of cell proliferation in pancreatic cancer.

Experimental and molecular pathology·2026
Same journal

MicroRNAs and predicted targets in the switch from monolayered to spheroids of cholangiocarcinoma cells.

Experimental and molecular pathology·2026
Same journal

Tumor-infiltrating CD8<sup>+</sup>Ki-67<sup>+</sup> and CD8<sup>+</sup>LAG-3<sup>+</sup> T cells are associated with improved patient survival in retroperitoneal dedifferentiated liposarcomas and leiomyosarcomas.

Experimental and molecular pathology·2026
Same journal

Citalopram enhances cisplatin-induced cytotoxicity in T24 bladder cancer cells: An in vitro study.

Experimental and molecular pathology·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Nanoparticle-based targeted drug delivery.

Rajesh Singh1, James W Lillard

  • 1Department of Microbiology and Immunology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Experimental and Molecular Pathology
|February 3, 2009
PubMed
Summary
This summary is machine-generated.

Nanotechnology utilizes nanoparticles with unique properties for advanced biomedical applications. A novel XPclad((c)) nanoparticle formulation shows promise in treating solid tumors and enhancing vaccinations.

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Nanotechnology involves manipulating matter at the nanometer scale.
  • Nanoparticles exhibit unique properties distinct from bulk materials.
  • These properties enable novel interactions with biological systems.

Purpose of the Study:

  • To provide biologists with an overview of nanotechnology.
  • To discuss the attributes of a novel XPclad((c)) nanoparticle formulation.
  • To highlight potential biomedical applications of this formulation.

Main Methods:

  • Overview of nanotechnology principles.
  • Discussion of nanoparticle characteristics (size, surface, solubility, multifunctionality).
  • Presentation of XPclad((c)) formulation data.

Main Results:

  • XPclad((c)) nanoparticles demonstrate efficacy in treating solid tumors.
  • The formulation is effective for single-dose vaccination.
  • Oral delivery of therapeutic proteins is feasible with this formulation.

Conclusions:

  • Nanoparticles offer significant potential for new biomedical applications.
  • XPclad((c)) nanoparticles present a promising multifunctional platform.
  • This technology can advance targeted therapies, diagnostics, and drug delivery.